Amino-Pyrazoles in Medicinal Chemistry: A Review.

aminopyrazole biological properties medicinal chemistry p38MAPK pyrazole

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Apr 2023
Historique:
received: 27 03 2023
revised: 11 04 2023
accepted: 20 04 2023
medline: 15 5 2023
pubmed: 13 5 2023
entrez: 13 5 2023
Statut: epublish

Résumé

A pyrazole nucleus is an easy-to-prepare scaffold with large therapeutic potential. Consequently, the search for new pyrazole-based compounds is of great interest to the academic community as well as industry. In the last ten years, a large number of papers and reviews on the design, synthesis, and biological evaluation of different classes of pyrazoles and many pyrazole-containing compounds have been published. However, an overview of pyrazole derivatives bearing a free amino group at the 3, 4, or 5 position (namely, 3-aminopyrazoles, 4-aminopyrazoles, and 5-aminopyrazoles, respectively) and their biological properties is still missing, despite the fact that aminopyrazoles are advantageous frameworks able to provide useful ligands for receptors or enzymes, such as p38MAPK, and different kinases, COX and others, as well as targets important for bacterial and virus infections. With the aim to fill this gap, the present review focuses on aminopyrazole-based compounds studied as active agents in different therapeutic areas, with particular attention on the design and structure-activity relationships defined by each class of compounds. In particular, the most relevant results have been obtained for anticancer/anti-inflammatory compounds, as the recent approval of Pirtobrutinib demonstrates. The data reported here are collected from different databases (Scifinder, Web of Science, Scopus, Google Scholar, and Pubmed) using "aminopyrazole" as the keyword.

Identifiants

pubmed: 37175540
pii: ijms24097834
doi: 10.3390/ijms24097834
pmc: PMC10177828
pii:
doi:

Substances chimiques

pirtobrutinib 0
Anti-Inflammatory Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Mini Rev Med Chem. 2007 Nov;7(11):1108-19
pubmed: 18045214
Blood. 2023 Feb 16;:
pubmed: 36796019
Molecules. 2021 Sep 22;26(19):
pubmed: 34641279
Clin Pharmacol Ther. 1965 Jan-Feb;6:25-30
pubmed: 14253281
ACS Chem Neurosci. 2020 Oct 21;11(20):3398-3408
pubmed: 32960565
J Med Chem. 2008 Jan 10;51(1):142-7
pubmed: 18072726
Eur J Med Chem. 2020 Dec 15;208:112768
pubmed: 32932211
Pathog Dis. 2017 Aug 31;75(6):
pubmed: 28859311
Med Pharmacol Exp Int J Exp Med. 1965;13(2):124-30
pubmed: 5897045
J Pharm Sci. 1974 Jul;63(7):1152-5
pubmed: 4850598
Bioorg Chem. 2020 Jan;95:103540
pubmed: 31911297
Bioorg Med Chem Lett. 2010 Feb 1;20(3):1293-7
pubmed: 20060294
ACS Omega. 2020 Sep 21;5(39):25104-25112
pubmed: 33043189
Pharmazie. 1999 Sep;54(9):705-6
pubmed: 10522275
Molecules. 2021 Dec 06;26(23):
pubmed: 34885993
RSC Med Chem. 2021 Sep 3;12(11):1868-1878
pubmed: 34841247
Semin Immunol. 2014 Jun;26(3):237-45
pubmed: 24647229
Med Chem. 2022;18(10):1060-1072
pubmed: 35410619
J Med Chem. 2006 Mar 9;49(5):1562-75
pubmed: 16509574
Eur J Med Chem. 2012 Jun;52:51-65
pubmed: 22464424
J Med Chem. 2020 Sep 10;63(17):9623-9649
pubmed: 32787097
Mini Rev Med Chem. 2015;15(4):272-99
pubmed: 25764318
Pharmaceutics. 2022 Aug 24;14(9):
pubmed: 36145518
Bioorg Med Chem Lett. 2001 Sep 3;11(17):2283-6
pubmed: 11527715
Lancet. 2021 Mar 6;397(10277):892-901
pubmed: 33676628
J Pharm Bioallied Sci. 2016 Jan-Mar;8(1):2-17
pubmed: 26957862
Front Biosci. 2008 May 01;13:3581-93
pubmed: 18508457
Eur J Med Chem. 2013 Jun;64:464-76
pubmed: 23669354
Med Chem. 2022;18(10):1044-1059
pubmed: 35240964
Eur J Pharm Sci. 2005 Sep;26(1):97-103
pubmed: 15990284
Bioorg Med Chem Lett. 2008 Jul 1;18(13):3745-8
pubmed: 18539026
Eur J Med Chem. 2015 Oct 20;103:583-93
pubmed: 26408817
Bioorg Chem. 2020 Apr;97:103470
pubmed: 32120072
Molecules. 2018 Jan 12;23(1):
pubmed: 29329257
Bioorg Med Chem Lett. 2013 May 1;23(9):2714-7
pubmed: 23511017
ChemMedChem. 2022 Mar 4;17(5):e202100670
pubmed: 34994095
Eur J Med Chem. 2012 Oct;56:254-62
pubmed: 23022735
Eur J Med Chem. 2010 May;45(5):1683-97
pubmed: 20110137
Eur J Med Chem. 2021 Feb 15;212:113134
pubmed: 33395624
Eur J Med Chem. 2010 Apr;45(4):1338-45
pubmed: 20064677
Molecules. 2020 Feb 18;25(4):
pubmed: 32085423
J Med Chem. 2009 Dec 10;52(23):7473-87
pubmed: 19645483
Anticancer Agents Med Chem. 2016;16(10):1288-300
pubmed: 26899188
Lancet. 2021 Mar 6;397(10277):855-857
pubmed: 33676615
Trends Pharmacol Sci. 2007 Jun;28(6):286-95
pubmed: 17482683
J Med Chem. 2000 Mar 9;43(5):1034-40
pubmed: 10715167
Eur J Med Chem. 2015 Jun 5;97:786-815
pubmed: 25555743
Antioxidants (Basel). 2023 Jan 17;12(2):
pubmed: 36829775
Farmaco Sci. 1970 Aug;25(8):592-617
pubmed: 5491604
Bioorg Chem. 2019 Aug;89:103023
pubmed: 31185391
Biomedicines. 2021 Dec 23;10(1):
pubmed: 35052697
Eur J Med Chem. 2010 Sep;45(9):3943-9
pubmed: 20573423
Molecules. 2022 Nov 09;27(22):
pubmed: 36431823
J Agric Food Chem. 2020 Jul 8;68(27):7093-7102
pubmed: 32530619
Nature. 2004 Mar 11;428(6979):198-202
pubmed: 15014504
Med Res Rev. 2003 Mar;23(2):146-89
pubmed: 12500287
Eur J Med Chem. 2013 Nov;69:735-53
pubmed: 24099993
Molecules. 2022 Sep 08;27(18):
pubmed: 36144549
Bioorg Chem. 2019 Aug;89:103007
pubmed: 31132600
Future Med Chem. 2010 Feb;2(2):203-13
pubmed: 21426187
Chem Rev. 2011 Nov 9;111(11):6984-7034
pubmed: 21806021
Arzneimittelforschung. 2002;52(6):482-8
pubmed: 12109050
Molecules. 2020 Jul 29;25(15):
pubmed: 32751358
Biomedicines. 2022 May 12;10(5):
pubmed: 35625859
J Med Chem. 2019 Dec 12;62(23):10757-10782
pubmed: 31702918
Arch Pharm (Weinheim). 2021 Jan;354(1):e2000214
pubmed: 32924168
Free Radic Res. 1999 Jun;30(6):471-7
pubmed: 10400459
Arch Pharm (Weinheim). 2011 May;344(5):279-86
pubmed: 21290430
Oncotarget. 2020 Sep 15;11(37):3459-3472
pubmed: 32973970
Nucleic Acids Symp Ser (Oxf). 2008;(52):137-8
pubmed: 18776291
ACS Omega. 2021 Feb 22;6(9):6088-6099
pubmed: 33718700
J Biol Chem. 2007 Nov 30;282(48):34663-71
pubmed: 17855341
Org Biomol Chem. 2016 Jan 21;14(3):947-56
pubmed: 26611938
Cell Death Discov. 2022 Apr 5;8(1):169
pubmed: 35383155
Environ Sci Pollut Res Int. 2015 Jan;22(1):5-34
pubmed: 25233913
Eur J Med Chem. 2020 Dec 15;208:112721
pubmed: 33035818
Bioorg Chem. 2020 May;98:103752
pubmed: 32197148
Curr Drug Targets. 2019;20(3):302-315
pubmed: 30073924
Nat Rev Drug Discov. 2003 Sep;2(9):717-26
pubmed: 12951578
Medchemcomm. 2018 Apr 12;9(6):963-968
pubmed: 30108985
J Med Chem. 2006 Nov 2;49(22):6500-9
pubmed: 17064068
Mol Divers. 2022 Aug 15;:
pubmed: 35969333

Auteurs

Matteo Lusardi (M)

Department of Pharmacy (DIFAR), Section of Medicinal Chemistry, University of Genoa, Viale Benedetto XV 3, 16132 Genoa, Italy.

Andrea Spallarossa (A)

Department of Pharmacy (DIFAR), Section of Medicinal Chemistry, University of Genoa, Viale Benedetto XV 3, 16132 Genoa, Italy.

Chiara Brullo (C)

Department of Pharmacy (DIFAR), Section of Medicinal Chemistry, University of Genoa, Viale Benedetto XV 3, 16132 Genoa, Italy.

Articles similaires

Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin

Yu Hu, Liu-Lin Chen, Zhen Ye et al.
1.00
Colitis, Ulcerative Humans Animals Drugs, Chinese Herbal Anti-Inflammatory Agents
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility
Animals Acetylcysteine Antioxidants Rats, Wistar Rats

Classifications MeSH